Herbert G. Sayer

3.4k total citations
90 papers, 2.1k citations indexed

About

Herbert G. Sayer is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Herbert G. Sayer has authored 90 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Hematology, 23 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Herbert G. Sayer's work include Hematopoietic Stem Cell Transplantation (42 papers), Multiple Myeloma Research and Treatments (19 papers) and Acute Myeloid Leukemia Research (19 papers). Herbert G. Sayer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (42 papers), Multiple Myeloma Research and Treatments (19 papers) and Acute Myeloid Leukemia Research (19 papers). Herbert G. Sayer collaborates with scholars based in Germany, Israel and United States. Herbert G. Sayer's co-authors include K. Höffken, Rainer Schwerdtfeger, Michael Kiehl, Nicolaus Kröger, Sebastian Scholl, Axel R. Zander, Tatjana Zabelina, J. Beyer, Christoph Kasper and Helmut Renges and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Herbert G. Sayer

88 papers receiving 2.1k citations

Peers

Countries citing papers authored by Herbert G. Sayer

Since Specialization

Citations

This map shows the geographic impact of Herbert G. Sayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert G. Sayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert G. Sayer more than expected).

Fields of papers citing papers by Herbert G. Sayer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert G. Sayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert G. Sayer. The network helps show where Herbert G. Sayer may publish in the future.

Co-authorship network of co-authors of Herbert G. Sayer

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert G. Sayer. A scholar is included among the top collaborators of Herbert G. Sayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert G. Sayer. Herbert G. Sayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort 2022 ·Oncology Research and Treatment ·Annamaria Brioli, (unknown), (unknown), Maria Madeleine Rüthrich, Sebastian Scholl, (unknown), Inken Hilgendorf, Thomas Ernst, Herbert G. Sayer, Andreas Hochhaus, Lars‐Olof Mügge, Marie von Lilienfeld‐Toal	6
2	Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma 2021 ·European Journal Of Haematology ·Christian Straka, Hans Salwender, Stefan Knop, Martin Vogel, (unknown), Bernd Metzner, Christian Langer, Herbert G. Sayer, Wolfram Jung, Heinz Dürk, Florian Bassermann, Martin Gramatzki, Wolf Rösler, Hans‐Heinrich Wolf, Wolfram Brugger, Monika Engelhardt, Thomas Fischer, Peter Liebisch, Hermann Einsele	4
3	Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy 2021 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Sebastian Scholl, Inken Hilgendorf, (unknown), (unknown), (unknown), Maximilian Fleischmann, Herbert G. Sayer, (unknown), Andreas Hochhaus, Ulf Schnetzke	1
4	The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey 2019 ·Annals of Hematology ·Annamaria Brioli, (unknown), Herbert G. Sayer, Sebastian Scholl, Thomas Ernst, Inken Hilgendorf, André Scherag, (unknown), Kristina Schilling, Andreas Hochhaus, Lars‐Olof Mügge, Marie von Lilienfeld‐Toal	36
5	Full Dose or Reduced Dose Melphalan (MEL) for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): A Single Center Analysis on 187 Consecutive Patients 2018 ·Blood ·Annamaria Brioli, (unknown), Lars‐Olof Mügge, Sebastian Scholl, Inken Hilgendorf, Herbert G. Sayer, (unknown), Thomas Ernst, Andreas Hochhaus, Marie von Lilienfeld‐Toal	4
6	Comparison of two dose levels of cyclophosphamide for successful stem cell mobilization in myeloma patients 2016 ·Journal of Cancer Research and Clinical Oncology ·Nils Winkelmann, (unknown), Inken Hilgendorf, Thomas Ernst, Herbert G. Sayer, (unknown), Lars‐Olof Mügge, Andreas Hochhaus, Sebastian Scholl	5
7	Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation 2015 ·Journal of Cancer Research and Clinical Oncology ·Christian Pfrepper, (unknown), Gerhard Behre, Thomas Schenk, Georg‐Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Haifa Kathrin Al‐Ali, Andreas Hochhaus, Dietger Niederwieser, Herbert G. Sayer	18
8	Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD) 2013 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Kristina Schilling, Frank D. Böhmer, Andreas Hochhaus, Herbert G. Sayer, Sebastian Scholl	9
9	Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission 2009 ·Leukemia ·Nadežda Basara, Antina Schulze, Ulrich Wedding, Martin Mohren, Axel Gerhardt, Christian Junghanß, N. Peter, Gottfried Dölken, Cornelia Becker, Simone Heyn, (unknown), Thoralf Lange, Rainer Krahl, Wolfram Pönisch, H.-J. Fricke, Herbert G. Sayer, Haifa Kathrin Al‐Ali, F Kamprad, Dietger Niederwieser, (unknown)	63
10	The use of ITS DNA sequence analysis and MALDI‐TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum 2008 ·Experimental Dermatology ·Florian Seyfarth, Mirjana Ziemer, Herbert G. Sayer, Anke Burmester, Marcel Erhard, Martin Welker, Sibylle Schliemann, Eberhard Straube, Uta‐Christina Hipler	45
11	Acute Abdomen by Varicella Zoster Virus Induced Gastritis after Autologous Peripheral Blood Stem Cell Transplantation in a Patient with Non-Hodgkin’s Lymphoma 2006 ·Acta Haematologica ·Sebastian Scholl, Michael Hocke, K. Höffken, Herbert G. Sayer	14
12	Impairment in functional status and survival in patients with acute myeloid leukaemia 2006 ·Journal of Cancer Research and Clinical Oncology ·Ulrich Wedding, Bernd Röhrig, Almuth Klippstein, (unknown), Herbert G. Sayer, K. Höffken	84
13	Respiratorische Insuffizienz und pulmonale Fibrose als Spätfolge einer Chemotherapie - induziert durch Sauerstoffexposition 2005 ·Pneumologie ·(unknown), Paula Brauer, Lars Hüter, Herbert G. Sayer, Roland P. Neumann, R. Braun	9
14	Safety and impact of donor‐type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch 2005 ·Transfusion ·Sebastian Scholl, (unknown), Lars‐Olof Mügge, Kristina Schilling, K. Höffken, Herbert G. Sayer	15
15	Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma 2005 ·British Journal of Haematology ·Nicolaus Kröger, Bronwen E. Shaw, Simona Iacobelli, Tatjana Zabelina, Karl S. Peggs, Avichai Shimoni, Arnon Nagler, Thomas Binder, Thomas Eiermann, J. Alejandro Madrigal, Rainer Schwerdtfeger, Michael Kiehl, Herbert G. Sayer, J. Beyer, Martin Bornhäuser, Francis Ayuk, Axel R. Zander, David I. Marks	82
16	Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors 2004 ·Bone Marrow Transplantation ·Christoph Kasper, Herbert G. Sayer, Lars‐Olof Mügge, K Schilling, Sebastian Scholl, (unknown), K. Höffken	20
17	Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes 2002 ·Journal of Cancer Research and Clinical Oncology ·Christoph Kasper, (unknown), Herbert G. Sayer	19
18	Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study 2002 ·Annals of Hematology ·Dietrich W. Beelen, H. Ottinger, Karin Kolbe, (unknown), Herbert G. Sayer, Wolfgang Knauf, (unknown), Christoph Scheid, UW Schaefer	24
19	Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group 2002 ·British Journal of Cancer ·Christian Kollmannsberger, Oliver Rick, (unknown), Thomas Kubin, Herbert G. Sayer, Marcus Hentrich, Manfred Welslau, Frank Mayer, M. Kuczyk, (unknown), Lothar Kanz, Carsten Bokemeyer	23
20	Bone marrow transplantation from partially HLA‐matched related donors in adults with leukaemia: The Experience at the University Hospital of Essen, Germany 1996 ·British Journal of Haematology ·H. Ottinger, Dietrich W. Beelen, Herbert G. Sayer, UW Schaefer, H. Grosse‐Wilde	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact